MET and hepatocellular carcinoma: MACC1 accelerated the activation of the HGF/c-Met/PI3K/AKT pathway and phosphorylated BAD, caspase 9, and FKHRL1, ultimately preventing hepatocellular carcinoma nuclear translocation and promoting apoptotic function [15].